fda

Ignite It
1 min read • July 23, 2019

FDA Issued Warning Letter To Curaleaf For Illegally Selling Unapproved Products Containing CBD Online With Unsubstantiated Claims

Ignite It
1 min read • June 19, 2019

FDA Is Working To Learn More About Effects CBD Could Cause In Body, Such As Toxicity To Liver, When Ingested Regularly Over Long Period Of Time

Ignite It
1 min read • June 19, 2019

FDA Says It ‘Recognizes The Significant Public Interest’ In Cannabis And Cannabis-Derived Compounds, Particularly CBD

Ignite It
2 min read • June 3, 2019

Ask Our Experts 6/2/2019: FDA Holds Public Hearing About CBD, What Happened?

Ignite It
2 min read • May 31, 2019

Regarding Today’s FDA Hearing On Cannabis-Derived Compounds

Ignite It
2 min read • May 30, 2019

Zynerba Pharma Highlights Will Present At FDA’s Public Hearing on Scientific Data and Information about Products Containing Cannabis or Cannabis-derived Compounds

Ignite It
4 min read • April 18, 2019

A Gap In Standards Leads To Industry Uncertainty About Synthetic CBD

Ignite It
21 min read • April 7, 2019

This Week’s Cannabis News: The FDA And CBD, The STATES Act, Cresco And Origin House, Europe And High Times

Ignite It
1 min read • December 20, 2018

FDA’s Gottlieb Says Will Advance New Steps To Better Define FDA’s Public Health Obligations In Area Of Cannabis

Ignite It
6 min read • December 20, 2018

The Daily Biotech Pulse: Tilray Inks Cannabis Drink Pact, Double Delight For Merck, FDA Snub For Spectrum

Ignite It
2 min read • October 2, 2018

Pyxus’ Indirect Canadian Subsidiary Receives ACMPR Cannabis Cultivation License From Health Canada

Ignite It
1 min read • September 24, 2018

Governor Cuomo Adds Pain Management To Medical Marijuana Treatment

Browse By Channels

 After-Hours Center
 Analyst Color
 Analyst Ratings
 Andy Barr
 Asia
 Asset Sales
 Be Your Own Boss
 Binary Options
 Biotech
 Bonds
 Broad U.S. Equity ETFs
 Buybacks
 california cannabis
 Cannabis
 cannabis clubs
 cannabis cultivation
 cannabis earnings
 cannabis farms
 cannabis study
 CBD
 Christopher Dillis
 CNBC
 Commodities
 Congress cannabis
 Congress hemp
 Contracts
 Crowdsourcing
 Cryptocurrency
 Currency ETFs
 Dividends
 Downgrades
 Earnings
 Earnings Beats
 Earnings Misses
 Econ #s
 Economics
 Education
 Emerging Market ETFs
 Emerging Markets
 Entertainment
 Entrepreneurship
 Equities
 ESG
 ETFs
 Eurozone
 Events
 Exclusives
 Fast Money
 FDA
 Federal Reserve
 Financial Advisors
 Financing
 Fintech
 first quarter earnings
 Forex
 Futures
 Gaming
 General
 germany cannabis
 Global
 Government
 Guidance
 Health Care
 Hedge Funds
 hemp bill
 hemp legalization
 hemp regulation
 hemp rules
 Hot
 IgniteIt Events
 illegal cannabis farms
 Initiation
 Insider Trades
 Insurance
 Interview
 intoxicating hemp-derived products
 Intraday Update
 IPOs
 James Comer
 Large Cap
 Latin America
 Legal
 Long Ideas
 M&A
 Macro Economic Events
 Macro Notification
 Management
 marijuana
 Market Summary
 Market-Moving Exclusives
 Markets
 Media
 Mid Cap
 Movers
 Movers & Shakers
 New ETFs
 News
 Offerings
 Opinion
 Options
 Penny Stocks
 Personal Finance
 Politics
 Pre-Market Outlook
 Press Releases
 Previews
 Price Target
 Psychedelics
 Psychology
 Real Estate
 Regulations
 REIT
 Reiteration
 Rescheduling
 Restaurants
 Retail Sales
 Reviews
 Rumors
 SEC
 Sector ETFs
 Short Ideas
 Short Sellers
 Signals
 Small Business
 Small Cap
 Small Cap Analysis
 Social Media
 Specialty ETFs
 Sports
 Sports Betting
 Startups
 Stock Split
 Success Stories
 Taxes
 Tech
 Technicals
 THC
 Top Stories
 Topics
 Trading Ideas
 Travel
 UC Berkeley Cannabis Research Center
 unlicensed cannabis
 Upgrades
 WIIM
 WNBA

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.